RESPONSE-ADAPTED TREATMENT WITH RITUXIMAB/BENDAMUSTINE/MITOXANTRONE/DEXAMETHASONE AND MAINTENANCE THERAPY WITH RITUXIMAB IN PATIENTS WITH FOLLICULAR LYMPHOMA IN RELAPSE OR REFRACTORY TO FIRST-LINE TREATMENT WITH IMMUNOCHEMOTHERAPY. RBMDGELTAMO08

被引：0
|
作者：
Francisco Javier, Penalver Parraga [1 ]
Jose Antonio, Marquez Navarro [2 ]
Nieto Soledad, Duran [3 ]
Castellano Pilar, Giraldo [4 ]
Sanz Carlos, Montalban [5 ]
Maria Jose, Ramirez Sanchez [6 ]
Juan Manuel, Sancho Cia [7 ]
Maria Jose, Terol Castera [8 ]
Francisco Javier, Capote Huelva [9 ]
Garcia Antonio, Gutierrez [10 ]
Gonzalez Blanca, Sanchez [11 ]
Silvestre Antonio, Salar [11 ]
Albendea Miguel, Canales [12 ]
Maria Dolores, Caballero Barrigon
机构：
[1] Hosp Univ Fdn Alcorcon, Madrid, Spain
[2] Hosp Basurto, Bilbao, Spain
[3] Complejo Hosp Jaen, Jaen, Spain
[4] Hosp Univ Miguel Servet, Zaragoza, Spain
[5] Hosp Univ Ramon & Cajal, Madrid, Spain
[6] Hosp Especialidades Jerez de la Frontera, Cadiz, Spain
[7] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
[8] Hosp Clin Univ Valencia, Valencia, Spain
[9] Hosp Puerta del Mar, Cadiz, Spain
[10] Hosp Univ Son Dureta, Palma De Mallorca, Spain
[11] Hosp del Mar, Barcelona, Spain
[12] Hosp Univ La Paz, Madrid, Spain
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
CO-011
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [31] Rituximab-bendamustine for first-line treatment of older patients with diffuse large B cell lymphoma: a multicenter analysis
    Zeremski, V.
    Kahl, C.
    Mohren, M.
    Jentsch-Ullrich, K.
    Eberhardt, J.
    Fischer, T.
    Schalk, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 45 - 46
  • [32] Cost-effectiveness of maintenance rituximab treatment after second line therapy in patients with follicular lymphoma in Sweden
    Kasteng, Frida
    Erlanson, Martin
    Hagberg, Hans
    Kimby, Eva
    Relander, Thomas
    Lundkvist, Jonas
    ACTA ONCOLOGICA, 2008, 47 (06) : 1029 - 1036
  • [33] LONG TERM OUTCOME OF PATIENTS WITH GASTRIC MARGINAL ZONE LYMPHOMA RECEIVING FLUDARABINE, MITOXANTRONE AND RITUXIMAB AS FIRST-LINE TREATMENT
    Cencini, E.
    Fabbri, A.
    Bartalucci, G.
    Schiattone, L.
    Papini, G.
    Gozzetti, A.
    Lauria, F.
    Bocchia, M.
    HAEMATOLOGICA, 2015, 100 : 145 - 145
  • [34] LONG TERM OUTCOME OF PATIENTS WITH GASTRIC MARGINAL ZONE LYMPHOMA RECEIVING FLUDARABINE, MITOXANTRONE AND RITUXIMAB AS FIRST-LINE TREATMENT
    Cencini, E.
    Fabbri, A.
    Bartalucci, G.
    Schiattone, L.
    Gozzetti, A.
    Lauria, F.
    Bocchia, M.
    HAEMATOLOGICA, 2015, 100 : 710 - 710
  • [35] PHARMACOECONOMIC ANALYSIS OF THE ADDITION OF RITUXIMAB TO FIRST-LINE CHEMOTHERAPY TREATMENT REGIMENS IN SPANISH PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA
    Rubio-Terres, C.
    Gomez-Codina, J.
    Rios, Herranz E.
    Castro, A. J.
    Varela, C.
    Ray, J. A.
    VALUE IN HEALTH, 2008, 11 (06) : A481 - A481
  • [36] Cost-Effectiveness of Obinutuzumab in Combination with Bendamustine Followed by Obinutuzumab Maintenance versus Bendamustine Alone in Treatment of Patients with Rituximab-Refractory Follicular Lymphoma in Norway
    Fredrik Salvesen Haukaas
    Audun Ohna
    Tania Krivasi
    Applied Health Economics and Health Policy, 2018, 16 : 569 - 577
  • [37] Cost-Effectiveness of Obinutuzumab in Combination with Bendamustine Followed by Obinutuzumab Maintenance versus Bendamustine Alone in Treatment of Patients with Rituximab-Refractory Follicular Lymphoma in Norway
    Haukaas, Fredrik Salvesen
    Ohna, Audun
    Krivasi, Tania
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2018, 16 (04) : 569 - 577
  • [38] Rituximab Maintenance In Patients with Chronic Lymphocytic Leukemia (CLL) Sustains the Response Obtained After First-Line Treatment with Rituximab Plus Fludarabine, Cyclophosphamide, and Mitoxantrone (R-FCM)
    Bosch, Francesc
    Villamor, Neus
    Abrisqueta, Pau
    Jose Terol, Maria
    Gonzalez-Barca, Eva
    Gonzalez, Marcos
    Ferra, Christelle
    Abella, Eugenia
    Delgado, Julio
    Garcia-Marco, Jose A.
    Gonzalez, Yolanda
    Carbonell, Felix
    Ferrer, Secundino
    Monzo, Encarna
    Jarque, Isidro
    Muntanola, Ana
    Constants, Mireia
    Escoda, Lourdes
    Montserrat, Emili
    BLOOD, 2010, 116 (21) : 594 - 595
  • [39] EFFICACY AND SAFETY OF BENDAMUSTINE IN ASSOCIATION WITH RITUXIMAB AS FIRST-LINE TREATMENT FOR PATIENTS WITH INDOLENT NON-HODGKIN LYMPHOMA OR MANTLE CELL LYMPHOMA
    Cencini, E.
    Fabbri, A.
    Iannuzzi, A.
    Schiattone, L.
    Brambilla, C. Zuanelli
    Bocchia, M.
    HAEMATOLOGICA, 2017, 102 : 112 - 112
  • [40] PERSPECTIVE: A Randomized, Phase 3 Study of Ibrutinib-Rituximab Versus Placebo-Rituximab Combination Therapy for First-Line Treatment of Follicular Lymphoma
    Flinn, Ian
    Gordon, Leo
    Rule, Simon
    Chen, Robert
    Kwei, Long
    Chu, Alvina
    Fowler, Nathan
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 : S12 - S13
12345